Indications for Mastectomy in DCIS

Absolute Indications for Mastectomy

The American Cancer Society recommends mastectomy for patients with multicentric disease, defined as two or more primary tumors located in different quadrants of the breast that cannot be encompassed by a single excision with acceptable cosmetic outcome 1, 2, 3, 4
Mastectomy is indicated for patients with diffuse malignant-appearing microcalcifications throughout the breast, which cannot be adequately removed through breast-conserving surgery 1, 2, 3, 4, 5
Persistently positive margins after reasonable surgical attempts at re-excision are an indication for mastectomy, as achieving negative margins is crucial for reducing the risk of recurrence 1, 2, 3, 4

The American Cancer Society suggests considering mastectomy for patients with extensive DCIS requiring near-total breast tissue removal, as achieving adequate negative margins would necessitate removing a large volume of breast tissue, compromising cosmetic outcome 1, 2, 4, 6
A large tumor-to-breast size ratio, particularly for DCIS extent >4 cm in patients with small breasts, may warrant consideration of mastectomy due to limited data supporting breast conservation effectiveness in larger lesions 1, 2, 6
Patients with collagen vascular disease, such as scleroderma and systemic lupus erythematosus, may be at increased risk for radiation-related morbidity and should be considered for mastectomy if breast-conserving surgery would require adjuvant radiation 1, 2, 6
Prior therapeutic radiation to the breast or chest wall precludes additional radiation therapy, making mastectomy a consideration for patients who have undergone previous radiation 1, 2, 6
Pregnancy is a contraindication to radiation therapy, and mastectomy should be considered for pregnant patients with DCIS who require surgical treatment 1, 2, 6

The National Comprehensive Cancer Network recommends performing sentinel lymph node biopsy at the time of definitive surgery for patients choosing mastectomy, as mastectomy permanently alters lymphatic drainage patterns and prevents future SLNB 5
Approximately 25% of patients with seemingly pure DCIS on initial biopsy will have invasive cancer at definitive surgery, which may ultimately require axillary staging, highlighting the importance of thorough margin assessment 5

The American Cancer Society advises against routine axillary lymph node dissection for pure DCIS, as complete ALND is not recommended unless pathologically documented invasive cancer or axillary metastases are identified 7
Surgical decisions should not be based solely on MRI findings, as MRI can overestimate disease extent, and suspicious findings should be histologically verified through MRI-guided biopsy before proceeding to mastectomy 5